Low- versus high-dose trimethoprim-sulfamethoxazole for the treatment of <i>Stenotrophomonas maltophilia</i> pneumonia
No differences in clinical success or adverse events were observed in patients with <i>S. maltophilia</i> pneumonia treated with either LD or HD TMP-SMX.
Authors
- Kelci Coe (ORCID: https://orcid.org/0000-0003-1012-5512)
- Joel R. Leininger (ORCID: https://orcid.org/0000-0002-1301-2225)
- Lynn Wardlow (ORCID: https://orcid.org/0000-0002-3539-4850)
- José A. Bazan (ORCID: https://orcid.org/0000-0002-8405-7156)
- Bradley Taranto
Institutions
- The Ohio State University Wexner Medical Center (US)
- Mount Carmel East (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.64
- Citations
- 2
- Primary Topic
- Infections and bacterial resistance
- Type
- article
- Field-Weighted Citation Impact
- 3.60